Clinical trials for Pancreas transplant

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Pancreas transplant. For all clinical trials, go to clinical trials search

This list shows clinical trials for Pancreas transplant

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Pancreas transplant
Title Recruitment status Location
A PHASE II, OPEN LABEL, PARALLEL GROUP, MULTI-CENTER STUDY TO COMPARE THE PHARMACOKINETICS OF TACROLIMUS IN ADULT SUBJECTS UNDERGOING PRIMARY ALLOGRAFT TRANSPLANTATION RECEIVING AN ADVAGRAF OR PROGRAF BASED IMMUNOSUPPRESSIVE REGIMEN, INCLUDING A LONG-TERM FOLLOW-UP - PMR-EC-1501 Not Recruiting United Kingdom
A Phase II, Open Label, Parallel Group, Multi-Center Study to Compare the Pharmacokinetics of Tacrolimus in Adult Subjects Undergoing Primary Allograft Transplantation Receiving an Advagraf® or Prograf® Based Immunosuppressive Regimen, Including a Long-Term Follow-Up. - PMR-EC-1501 Not Recruiting United Kingdom
A study to compare blood levels of Tacrolimus in adult patients undgoing a first transplantation and being treated with Advagraf or Prograf based anti-rejection therapy, including checking of safety and effectivity in the long term. Authorised United Kingdom
A PHASE II, OPEN LABEL, PARALLEL GROUP, MULTI-CENTER STUDY TO COMPARE THE PHARMACOKINETICS OF TACROLIMUS IN ADULT SUBJECTS UNDERGOING PRIMARY ALLOGRAFT TRANSPLANTATION RECEIVING AN ADVAGRAF OR PROGRAF BASED IMMUNOSUPPRESSIVE REGIMEN, INCLUDING A LONG-TERM FOLLOW-UP - PMR-EC-1501 Not Recruiting Austria
A PHASE II, OPEN LABEL, PARALLEL GROUP, MULTI-CENTER STUDY TO COMPARE THE PHARMACOKINETICS OF TACROLIMUS IN ADULT SUBJECTS UNDERGOING PRIMARY ALLOGRAFT TRANSPLANTATION RECEIVING AN ADVAGRAF OR PROGRAF BASED IMMUNOSUPPRESSIVE REGIMEN, INCLUDING A LONG-TERM FOLLOW-UP - PMR-EC-1501 Not Recruiting Italy
Combined liver-pancreas en-bloc transplantation in patients with end-stage liver disease and insulin dependent type2 diabetes mellitus: a multicenter, prospective, matched pair study (LPILDStudy) Not Recruiting China
Combined liver-pancreas en-bloc transplantation in patients with end-stage liver disease and insulin dependent type2 diabetes mellitus: a multicenter, prospective, matched pair study (LPILDStudy) Not Recruiting China
A Phase II, Open Label, Parallel Group, Multi-Center Study to Compare the Pharmacokinetics of Tacrolimus in Adult Subjects Undergoing Primary Allograft Transplantation Receiving an Advagraf® or Prograf® Based Immunosuppressive Regimen, Including a Long-Term Follow-Up. - PMR-EC-1501 Not Recruiting Austria
A Phase II, Open Label, Parallel Group, Multi-Center Study to Compare the Pharmacokinetics of Tacrolimus in Adult Subjects Undergoing Primary Allograft Transplantation Receiving an Advagraf® or Prograf® Based Immunosuppressive Regimen, Including a Long-Term Follow-Up. - PMR-EC-1501 Not Recruiting Italy
A study to compare blood levels of Tacrolimus in adult patients undgoing a first transplantation and being treated with Advagraf or Prograf based anti-rejection therapy, including checking of safety and effectivity in the long term. Authorised Austria

Page last reviewed: 20/06/2016

Next review due: 01/12/2018